[144] ARTIVION, INC. SEC Filing

Rhea-AI Filing Summary

AORT filed a Form 144 indicating an intended sale of restricted or control securities. The filing covers a planned sale of 6,394 common shares through Fidelity Brokerage Services LLC, with an aggregate market value of $288,816.98. These shares are part of a class with 47,374,939 shares outstanding, and the approximate sale date is 11/17/2025 on the NYSE.

The seller acquired these shares on 11/17/2025 through an option granted on 03/05/2019, paid in cash. Over the prior three months, John E. Davis reported additional sales of common shares: 3,373 shares on 11/10/2025 for $150,499.55, 6,563 shares on 11/13/2025 for $300,968.02, and 6,393 shares on 11/14/2025 for $285,575.31.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	6394	288816.98	47374939	11/17/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/17/2025	Option Granted - 03/05/2019	Issuer			6394	11/17/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
John E. Davis 1655 Roberts Boulevard NW Kennesaw GA 30144	Common	11/10/2025	3373	150499.55
John E. Davis 1655 Roberts Boulevard NW Kennesaw GA 30144	Common	11/13/2025	6563	300968.02
John E. Davis 1655 Roberts Boulevard NW Kennesaw GA 30144	Common	11/14/2025	6393	285575.31

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the AORT Form 144 filing report?

The Form 144 filing for AORT reports the planned sale of 6,394 common shares through Fidelity Brokerage Services LLC, with an aggregate market value of $288,816.98, to be sold on or about 11/17/2025 on the NYSE.

How many AORT shares are planned to be sold and what is their value?

The filing indicates an intended sale of 6,394 common shares of AORT with an aggregate market value of $288,816.98.

How many AORT common shares are outstanding according to the Form 144?

The Form 144 states that there are 47,374,939 common shares outstanding for the issuer at the time of the filing.

When and how were the AORT shares in this Form 144 acquired?

The 6,394 common shares were acquired on 11/17/2025 through an option granted on 03/05/2019, and the payment for the shares was made in cash.

What AORT stock sales did John E. Davis report over the past three months?

John E. Davis reported selling AORT common shares on three dates: 3,373 shares on 11/10/2025 for $150,499.55, 6,563 shares on 11/13/2025 for $300,968.02, and 6,393 shares on 11/14/2025 for $285,575.31.

Which broker is handling the AORT Form 144 share sale?

The planned sale of 6,394 AORT common shares is to be executed through Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI 02917.

On which exchange are the AORT shares in this Form 144 expected to be sold?

The Form 144 indicates that the 6,394 common shares are expected to be sold on the NYSE.